dermatan sulfate has been researched along with Malignant Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X; Li, H; Li, S; Ren, J; Shi, H; Tong, R; Zhang, F; Zhang, Q | 1 |
| Li, S; Yu, Y; Zhang, F; Zhang, Q | 1 |
| Kim, D; Kim, IS; Kim, SH; Kwak, G; Kwon, IC; Nam, GH; Wang, SY; Yeo, Y | 1 |
| Denholm, EM; Lin, YQ; Silver, PJ | 1 |
| Biswas, C | 1 |
5 other study(ies) available for dermatan sulfate and Malignant Melanoma
| Article | Year |
|---|---|
ROS-triggered nanoinducer based on dermatan sulfate enhances immunogenic cell death in melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dermatan Sulfate; Doxorubicin; Humans; Immunogenic Cell Death; Melanoma; Reactive Oxygen Species | 2022 |
A dermatan sulfate-functionalized biomimetic nanocarrier for melanoma targeted chemotherapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomimetic Materials; Camptothecin; Cell Proliferation; Dermatan Sulfate; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Melanoma; Mice; Molecular Structure; Nanoparticles; Particle Size; Skin Neoplasms; Surface Properties; Tumor Cells, Cultured | 2020 |
Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dermatan Sulfate; Drug Screening Assays, Antitumor; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; NIH 3T3 Cells; Polyethyleneimine; Programmed Cell Death 1 Receptor | 2017 |
Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion.
Topics: Animals; Apoptosis; Cattle; Cell Division; Cell Movement; Cells, Cultured; Chondroitin Sulfates; Chondroitinases and Chondroitin Lyases; Dermatan Sulfate; Dose-Response Relationship, Drug; Endothelium, Vascular; Gelatinases; Humans; Melanoma; Neoplasm Metastasis; Neovascularization, Pathologic; Neovascularization, Physiologic; Tumor Cells, Cultured | 2001 |
Heparin and heparan sulfate binding sites on B-16 melanoma cells.
Topics: Animals; Binding Sites; Cell Line; Chondroitin Sulfates; Dermatan Sulfate; Glycosaminoglycans; Heparin; Heparitin Sulfate; Hyaluronic Acid; Kinetics; Melanoma; Membranes; Receptors, Cell Surface | 1988 |